PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: RNCOS E-Services (P) Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Generics to Penetrate 26% Pharma Market in Canada Says New Report - By 2012, generics is projected to account for about 26% of total Canadian pharmaceutical market as the penetration of generics is growing rapidly in the country, says RNCOS research
Generics to Penetrate 26% Pharma Market in Canada Says New Report

 

NewswireToday - /newswire/ - Delhi, New Delhi, India, 2008/06/09 - By 2012, generics is projected to account for about 26% of total Canadian pharmaceutical market as the penetration of generics is growing rapidly in the country, says RNCOS research.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

According to the latest RNCOS research report, “Generic Drug Market in Canada”, generics is increasingly penetrating the pharmaceutical market of Canada, and by 2012, the segment is forecasted to make up for around 26% of the total Canadian pharmaceutical sales.

The report recognizes tremendous cost savings provided by the generic drugs as one of the major growth drivers for the Canadian generics market. This is because generics, unlike branded drugs, do not require costly clinical trials and development process and thus, the prices of generics are lower in comparison to other branded drugs. For instance, average price of a generic drug was US$ 24.68 (CA$ 24.75) in 2006, which is nearly 61% less than the price of a branded drug.

Therefore, due to low prices of generics, consumers and insurance companies saved around CA$ 500 Million (US$ 500 Million) in 2006 in drug purchases. Also, due to the use of generics in place of branded drugs, consumers have saved big amounts by paying lower copayments, while both private as well as public insurance companies have saved from low prices of drugs. Resultantly, generics usage is being strongly pitched in Canada.

Furthermore, patent expiration of major blockbuster drugs is also considered as a major factor influencing the growth of generics market in the country. According to the Canadian IPR (Intellectual Property Rights) laws, generic makers can design generic versions of branded drugs after the expiration of their patent. Thus, all the drugs, which have lost their market exclusivity and patent in Canada, can be sold as generic versions.

And as several blockbusters are anticipated to lose their patent protection in short-term (2008-2012), this will pave the way for the growth of generics market.

“Generic Drug Market in Canada” provides complete evaluation of positive as well as negative factors which differentiate the country from European and the US generics market. The report also identifies the reasons for influx of foreign players to the Canadian market. Also, it gives objective analysis on the generics market and based on that, provides forecast on healthcare spending, share of branded & generic drug sales in pharmaceutical market, share of branded & generic drugs by prescription, and sales analysis of pharmaceuticals, generic drug and branded drug.

About RNCOS

RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of industry experts who analyze data collected from credible sources. They provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: RNCOS E-Services (P) Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Generics to Penetrate 26% Pharma Market in Canada Says New Report

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Shushmul Maheshwari 
+91 12 04224700 press[.]rncos.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any RNCOS E-Services (P) Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From RNCOS E-Services (P) Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics
BD to Invest $60 Million in Nebraska Manufacturing Facility
MDxHealth Announces New Contract with MediNcrease Health Plans Regarding ConfirmMDx and SelectMDx
Pulse Certified As A Level Four Multichannel Content Agency by Veeva
Earthly Mist - Opioid-Alternative Painkiller, Kratom Now Available in Oklahoma City
MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Intrinsic Executive Search Ltd

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)